Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on West Pharmaceutical Services

Share:
Related WST
5 Notable Stocks Trading Ex-Dividend Monday, October 17
Mid-Afternoon Market Update: Dow Surges 125 Points; FedEx Shares Jump Following Upbeat Earnings

In a report published Monday, Jefferies & Company reiterated its Hold rating on West Pharmaceutical Services (NYSE: WST), and raised its price target from $45.00 to $49.00.

Jefferies noted, “WST continues to see progress in shifting customers to high value (and higher margin) packaging products. The company has also benefited from accelerated demand from clients, who are building inventory and launching new products. We expected that to moderate sooner than now, but still expect it to diminish in the future. We are raising EPS based on the recent performance, while maintaining future growth rates.”

West Pharmaceutical Services closed on Friday at $52.66.

Latest Ratings for WST

DateFirmActionFromTo
Oct 2016Wells FargoUpgradesMarket PerformOutperform
Sep 2016Wells FargoDowngradesOutperformMarket Perform
Jul 2016JefferiesMaintainsHold

View More Analyst Ratings for WST
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (WST)

View Comments and Join the Discussion!